| Pneumocystis pneumonia CF Thomas Jr, AH Limper New England Journal of Medicine 350 (24), 2487-2498, 2004 | 1314 | 2004 |
| Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. TJ Broekelmann, AH Limper, TV Colby, JA McDonald Proceedings of the National Academy of Sciences 88 (15), 6642-6646, 1991 | 1035 | 1991 |
| An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients AH Limper, KS Knox, GA Sarosi, NM Ampel, JE Bennett, A Catanzaro, ... American journal of respiratory and critical care medicine 183 (1), 96-128, 2011 | 791 | 2011 |
| Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy SH Yale, AH Limper Mayo Clinic Proceedings 71 (1), 5-13, 1996 | 727 | 1996 |
| Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis CE Daniels, MC Wilkes, M Edens, TJ Kottom, SJ Murphy, AH Limper, ... The Journal of clinical investigation 114 (9), 1308-1316, 2004 | 724 | 2004 |
| Tracheobronchial foreign bodies in adults AH Limper, UBS Prakash Annals of internal medicine 112 (8), 604-609, 1990 | 672 | 1990 |
| Pulmonary Langerhans'-cell histiocytosis R Vassallo, JH Ryu, TV Colby, T Hartman, AH Limper New England Journal of Medicine 342 (26), 1969-1978, 2000 | 622 | 2000 |
| Stretch induces cytokine release by alveolar epithelial cells in vitro NE Vlahakis, MA Schroeder, AH Limper, RD Hubmayr American Journal of Physiology-Lung Cellular and Molecular Physiology 277 (1 …, 1999 | 587 | 1999 |
| Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults R Vassallo, JH Ryu, DR Schroeder, PA Decker, AH Limper New England Journal of Medicine 346 (7), 484-490, 2002 | 576 | 2002 |
| Pneumocystis carinii pneumonia AH Limper, KP Offord, TF Smith, WJ Martin Am Rev Respir Dis 140, 1204-1209, 1989 | 520 | 1989 |
| Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results CE Daniels, JA Lasky, AH Limper, K Mieras, E Gabor, DR Schroeder American journal of respiratory and critical care medicine 181 (6), 604-610, 2010 | 474 | 2010 |
| Fungal infections in HIV/AIDS AH Limper, A Adenis, T Le, TS Harrison The Lancet Infectious Diseases 17 (11), e334-e343, 2017 | 455 | 2017 |
| Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis JP Utz, AH Limper, S Kalra, U Specks, JP Scott, Z Vuk-Pavlovic, ... Chest 124 (1), 177-185, 2003 | 427 | 2003 |
| Current insights into the biology and pathogenesis of Pneumocystis pneumonia CF Thomas Jr, AH Limper Nature Reviews Microbiology 5 (4), 298-308, 2007 | 318 | 2007 |
| High-dimensional ab initio potential energy surfaces for reaction dynamics calculations JM Bowman, G Czako, B Fu Physical Chemistry Chemical Physics 13 (18), 8094-8111, 2011 | 301 | 2011 |
| Exploring animal models that resemble idiopathic pulmonary fibrosis J Tashiro, GA Rubio, AH Limper, K Williams, SJ Elliot, I Ninou, V Aidinis, ... Frontiers in medicine 4, 118, 2017 | 285 | 2017 |
| Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-κB XM Chen, SP O’Hara, JB Nelson, PL Splinter, AJ Small, PS Tietz, ... The Journal of Immunology 175 (11), 7447-7456, 2005 | 253 | 2005 |
| Update on the diagnosis and treatment of Pneumocystis pneumonia EM Carmona, AH Limper Therapeutic advances in respiratory disease 5 (1), 41-59, 2011 | 249 | 2011 |
| The fourth age of quantum chemistry: molecules in motion AG Csaszar, C Fabri, T Szidarovszky, E Matyus, T Furtenbacher, G Czako Physical Chemistry Chemical Physics 14 (3), 1085-1106, 2012 | 236 | 2012 |
| Toward black-box-type full-and reduced-dimensional variational (ro) vibrational computations E Mátyus, G Czakó, AG Császár The Journal of chemical physics 130 (13), 2009 | 236 | 2009 |
